Eurofins Scientific SE (ERFSF)
USD 49.72
(0.0%)
USD 49.72
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.21 Billion EUR | -11.09% |
| 2022 | 1.36 Billion EUR | -20.41% |
| 2021 | 1.69 Billion EUR | 28.46% |
| 2020 | 1.32 Billion EUR | 62.91% |
| 2019 | 864.9 Million EUR | 27.53% |
| 2018 | 656.8 Million EUR | 26.76% |
| 2017 | 521.61 Million EUR | 10.73% |
| 2016 | 484.51 Million EUR | 38.57% |
| 2015 | 319.95 Million EUR | 45.68% |
| 2014 | 224.92 Million EUR | 22.44% |
| 2013 | 185.56 Million EUR | 11.35% |
| 2012 | 160.79 Million EUR | 18.09% |
| 2011 | 140.55 Million EUR | 51.04% |
| 2010 | 91.98 Million EUR | 57.17% |
| 2009 | 59.21 Million EUR | -28.07% |
| 2008 | 80.92 Million EUR | 20.15% |
| 2007 | 67.76 Million EUR | 19.92% |
| 2006 | 57.12 Million EUR | 39.3% |
| 2005 | 40.52 Million EUR | 52.27% |
| 2004 | 26.44 Million EUR | 41.97% |
| 2003 | 18.97 Million EUR | 9.15% |
| 2002 | 17.37 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 753.2 Million EUR | 0.0% |
| 2023 Q2 | 577.6 Million EUR | 0.0% |
| 2023 FY | - EUR | -11.09% |
| 2023 Q4 | 633.5 Million EUR | 0.0% |
| 2022 Q4 | 603.2 Million EUR | 0.0% |
| 2022 FY | - EUR | -20.41% |
| 2022 Q2 | 788.9 Million EUR | 0.0% |
| 2021 FY | - EUR | 28.46% |
| 2021 Q2 | 978.6 Million EUR | 0.0% |
| 2021 Q4 | 839.3 Million EUR | 0.0% |
| 2020 Q4 | 883.8 Million EUR | 0.0% |
| 2020 FY | - EUR | 62.91% |
| 2020 Q2 | 450.5 Million EUR | 0.0% |
| 2019 Q2 | 314.39 Million EUR | 0.0% |
| 2019 FY | - EUR | 27.53% |
| 2019 Q4 | 448.1 Million EUR | 0.0% |
| 2018 Q2 | 290.63 Million EUR | 0.0% |
| 2018 FY | - EUR | 26.76% |
| 2018 Q4 | 416.96 Million EUR | 0.0% |
| 2017 Q2 | 248.85 Million EUR | 0.0% |
| 2017 Q4 | 300.28 Million EUR | 0.0% |
| 2017 FY | - EUR | 10.73% |
| 2016 Q2 | 207.64 Million EUR | 0.0% |
| 2016 Q4 | 264.77 Million EUR | 0.0% |
| 2016 FY | - EUR | 38.57% |
| 2015 FY | - EUR | 45.68% |
| 2015 Q2 | 132.72 Million EUR | 0.0% |
| 2015 Q4 | 220.72 Million EUR | 0.0% |
| 2014 FY | - EUR | 22.44% |
| 2014 Q4 | 149.09 Million EUR | 0.0% |
| 2014 Q2 | 106.85 Million EUR | 0.0% |
| 2013 Q4 | 102.23 Million EUR | 0.0% |
| 2013 Q2 | 97.59 Million EUR | 0.0% |
| 2013 FY | - EUR | 11.35% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | - EUR | 18.09% |
| 2011 Q1 | 17.31 Million EUR | -72.03% |
| 2011 Q4 | 47.27 Million EUR | 15.24% |
| 2011 Q2 | 34.93 Million EUR | 101.76% |
| 2011 Q3 | 41.02 Million EUR | 17.42% |
| 2011 FY | - EUR | 51.04% |
| 2010 Q1 | 10.58 Million EUR | -63.79% |
| 2010 Q2 | 24.34 Million EUR | 130.03% |
| 2010 Q3 | 64.45 Million EUR | 164.83% |
| 2010 Q4 | 61.91 Million EUR | -3.95% |
| 2010 FY | - EUR | 57.17% |
| 2009 FY | - EUR | -28.07% |
| 2009 Q4 | 29.21 Million EUR | -41.09% |
| 2009 Q3 | 49.59 Million EUR | 189.01% |
| 2009 Q1 | 11.16 Million EUR | 0.0% |
| 2009 Q2 | 17.16 Million EUR | 53.75% |
| 2008 FY | - EUR | 20.15% |
| 2007 FY | - EUR | 19.92% |
| 2006 FY | - EUR | 39.3% |
| 2005 FY | - EUR | 52.27% |
| 2004 FY | - EUR | 41.97% |
| 2003 FY | - EUR | 9.15% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 104743.164% |
| Arrayit Corporation | -3.07 Million USD | 39645.15% |
| Atlantic International Corp. | -5.38 Million USD | 22680.693% |
| Biocept, Inc. | -30.24 Million USD | 4124.338% |
| Bioqual, Inc. | 3.03 Million USD | -40035.345% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 160786.582% |
| DermTech, Inc. | -97.89 Million USD | 1343.194% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 58.238% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 6112.116% |
| iMD Companies, Inc. | -154.65 Thousand USD | 786992.454% |
| IDenta Corp. | 71.58 Thousand USD | -1699929.335% |
| Interpace Biosciences, Inc. | 3.83 Million USD | -31617.488% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -3145415.637% |
| InVitro International | 6680.00 USD | -18218462.874% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 22487.785% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 10029768.7% |
| Medical Imaging Corp. | -896.74 Thousand USD | 135813.505% |
| NovelStem International Corp. | -3.78 Million USD | 32246.45% |
| Optigenex Inc. | -1.18 Million USD | 102651.225% |
| PharmChem, Inc. | 1.05 Million USD | -115385.714% |
| Proteome Sciences plc | -1.13 Million USD | 107136.06% |
| Response Genetics, Inc | -19.66 Million USD | 6288.345% |
| Rennova Health, Inc. | -234.81 Thousand USD | 518380.348% |
| RushNet, Inc. | -614.85 Thousand USD | 198033.812% |
| ScreenPro Security Inc. | -3.43 Million USD | 35530.548% |
| Stella Diagnostics Inc. | -5.7 Million USD | 21423.082% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 11949.887% |
| Todos Medical Ltd. | -9.39 Million USD | 13055.078% |